blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1301540

EP1301540 - RGD (ARG-GLY-ASP) COUPLED TO NEUROPEPTIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.06.2005
Database last updated on 25.09.2024
Most recent event   Tooltip14.12.2007Lapse of the patent in a contracting state
New state(s): PT
published on 16.01.2008  [2008/03]
Applicant(s)For all designated states
BioSynthema Inc.
379 Woodmere Nook Ct. St Charles
Missouri 63303 / US
[N/P]
Former [2003/36]For all designated states
BioSynthema Inc.
379 Woodmere Nook Ct.
St Charles, Missouri 63303 / US
Former [2003/16]For all designated states
MALLINCKRODT, INC.
P.O. Box 5840 675 McDonnell Blvd.
St. Louis, MO 63134 / US
Inventor(s)01 / DE JONG, Marion
Eleonorastraat 119
NL-3135 PA Vlaardingen / NL
02 / KRENNING, Eric, Paul
Hoflaan 71
NL-3062 JC Rotterdam / NL
03 / VAN HAGEN, Petrus, Martinus
Goosse van der Windstraat 14
NL-3032 XM Rotterdam / NL
 [2003/16]
Representative(s)Hooiveld, Arjen Jan Winfried
Arnold & Siedsma
Bezuidenhoutseweg 57
2594 AC The Hague / NL
[N/P]
Former [2003/16]Hooiveld, Arjen Jan Winfried
Arnold & Siedsma Sweelinckplein 1
2517 GK Den Haag / NL
Application number, filing date01947245.526.04.2001
[2003/16]
WO2001EP04764
Priority number, dateEP2000020149926.04.2000         Original published format: EP 00201499
[2003/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0181426
Date:01.11.2001
Language:EN
[2001/44]
Type: A2 Application without search report 
No.:EP1301540
Date:16.04.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 01.11.2001 takes the place of the publication of the European patent application.
[2003/16]
Type: B1 Patent specification 
No.:EP1301540
Date:28.07.2004
Language:EN
[2004/31]
Search report(s)International search report - published on:EP27.06.2002
ClassificationIPC:C07K19/00
[2003/16]
CPC:
C07K5/1019 (EP,US); A61K47/62 (EP,US); A61K51/082 (EP,US);
A61K51/083 (EP,US); A61K51/088 (EP,US); A61P35/00 (EP);
C07K14/575 (EP,US); C07K14/57563 (EP,US); C07K14/595 (EP,US);
C07K14/655 (EP,US); C07K14/6555 (EP,US); C07K14/75 (EP,US);
C07K14/78 (EP,US); C07K19/00 (EP,US); C07K5/0817 (EP,US);
C07K7/086 (EP,US); C07K7/22 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/16]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:AN NEUROPEPTIDE GEBUNDENES RGD (ARG-GLY-ASP)[2003/16]
English:RGD (ARG-GLY-ASP) COUPLED TO NEUROPEPTIDES[2003/16]
French:RGD (ARG-GLY-ASP) COUPLE A DES NEUROPEPTIDES[2004/01]
Former [2003/16]RGD (ARG-GLY-ASP) COUPLE A DES (NEURO)PEPTIDES
Entry into regional phase22.10.2002National basic fee paid 
22.10.2002Designation fee(s) paid 
22.10.2002Examination fee paid 
Examination procedure21.11.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.10.2002Examination requested  [2003/16]
15.05.2003Despatch of a communication from the examining division (Time limit: M04)
15.09.2003Reply to a communication from the examining division
01.12.2003Communication of intention to grant the patent
04.05.2004Fee for grant paid
04.05.2004Fee for publishing/printing paid
Divisional application(s)EP04101401.0  / EP1452543
Opposition(s)29.04.2005No opposition filed within time limit [2005/29]
Fees paidRenewal fee
26.06.2003Renewal fee patent year 03
28.04.2004Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.04.200303   M06   Fee paid on   26.06.2003
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT28.07.2004
FI28.07.2004
IT28.07.2004
TR28.07.2004
DK28.10.2004
GR28.10.2004
SE28.10.2004
PT28.12.2004
CY26.04.2005
IE26.04.2005
LU26.04.2005
[2008/03]
Former [2007/36]AT28.07.2004
FI28.07.2004
IT28.07.2004
TR28.07.2004
DK28.10.2004
GR28.10.2004
SE28.10.2004
CY26.04.2005
IE26.04.2005
LU26.04.2005
Former [2007/26]AT28.07.2004
FI28.07.2004
TR28.07.2004
DK28.10.2004
GR28.10.2004
SE28.10.2004
CY26.04.2005
IE26.04.2005
LU26.04.2005
Former [2007/20]AT28.07.2004
FI28.07.2004
TR28.07.2004
DK28.10.2004
GR28.10.2004
SE28.10.2004
CY26.04.2005
IE26.04.2005
Former [2006/51]AT28.07.2004
FI28.07.2004
TR28.07.2004
DK28.10.2004
GR28.10.2004
SE28.10.2004
IE26.04.2005
Former [2006/25]AT28.07.2004
FI28.07.2004
DK28.10.2004
GR28.10.2004
SE28.10.2004
IE26.04.2005
Former [2005/22]AT28.07.2004
FI28.07.2004
DK28.10.2004
GR28.10.2004
SE28.10.2004
Former [2005/18]AT28.07.2004
FI28.07.2004
GR28.10.2004
SE28.10.2004
Former [2005/13]AT28.07.2004
FI28.07.2004
SE28.10.2004
Former [2005/11]FI28.07.2004
SE28.10.2004
Former [2005/10]SE28.10.2004
Cited inInternational search[Y]EP0385659  (UNIV FUJITA HEALTH [JP], et al) [Y] 1 * See page 2 (esp. lines 29-44) - page 3, (line 29) *;
 [Y]  - VELLA ET AL, "Grafting an RGD motif onto an epidermal growth factor-like module: Chemical synthesis and functional characterization of the chimeric molecule", JOURNAL OF PEPTIDE RESEARCH, MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, DK, (199911), vol. 54, no. 5, ISSN 1397-002X, pages 415 - 426, XP000851981 [Y] 1 * See page 416, second column *

DOI:   http://dx.doi.org/10.1034/j.1399-3011.1999.00137.x
 [Y]  - DE JONG ET AL, "Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues", QUARTERLY JOURNAL OF NUCLEAR MEDICINE, MILAN, IT, (199912), vol. 43, no. 4, ISSN 1125-0135, pages 356 - 366, XP000978316 [Y] 1 * See page 356 (Abstract) and 357 (Figure 1) *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.